Trade BBTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bambusa Therapeutics, Inc. (BBTX) is trading at US$15.55, down 2.20% today as of Nov 19, 16:00 EST. The company has a market capitalisation of US$808.91M. Over the past 52 weeks, BBTX has traded between US$13.60 and US$17.65. On Syfe you can trade BBTX with $0 commission and add it to your watchlist.
| Previous close | US$15.90 |
|---|---|
| Market cap | US$808.91M |
| 52-week range | US$13.60 – US$17.65 |
| Volume | 151.5K |
| Exchange | US |
Bambusa Therapeutics, Inc.
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.
Bambusa Therapeutics, Inc. (BBTX) stock is trading at US$15.55, -2.20% from the previous close of US$15.90.
The market cap for Bambusa Therapeutics, Inc. (BBTX) stock is approximately US$808.91M.
The 52-week high for Bambusa Therapeutics, Inc. (BBTX) stock is US$17.65.
The 52-week low for Bambusa Therapeutics, Inc. (BBTX) stock is US$13.60.
Bambusa Therapeutics, Inc. (BBTX) does not currently pay a dividend.
Stay on top of BBTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore